AgeX Therapeutics Aktie (A2N8PC

Was macht AgeX Therapeutics?

Unternehmensprofil

AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

Chart der AgeX Therapeutics Aktie

Charttool öffnen

Aktuelle Nachrichten zu AgeX Therapeutics

Weitere Nachrichten

Das berichten andere über AgeX Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

MARKER THERAPEUTICS (MRKR) delivered earnings and revenue surprises of +80.49% and +83.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to...

Apogee Therapeutics Aktie: J&J-Flop öffnet Tür für APG279

New York (www.aktiencheck.de) - Apogee Therapeutics-Aktienanalyse von BTIG:Die Analysten von BTIG haben das "buy"-Rating für die Aktie von Apogee Therapeutics Inc. (ISIN:...

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 152.4% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly...

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"), today announced...